Wealthfront Advisers’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.26M Sell
15,431
-7,068
-31% -$2.87M 0.02% 328
2025
Q1
$11.2M Sell
22,499
-26
-0.1% -$12.9K 0.03% 180
2024
Q4
$11.7M Buy
22,525
+945
+4% +$492K 0.03% 159
2024
Q3
$13.3M Buy
21,580
+346
+2% +$214K 0.04% 134
2024
Q2
$11.7M Buy
21,234
+38
+0.2% +$21K 0.04% 133
2024
Q1
$12.3M Buy
21,196
+1,374
+7% +$799K 0.04% 127
2023
Q4
$10.5M Sell
19,822
-1,390
-7% -$738K 0.04% 131
2023
Q3
$10.7M Buy
21,212
+817
+4% +$414K 0.05% 115
2023
Q2
$10.6M Sell
20,395
-7,095
-26% -$3.7M 0.05% 120
2023
Q1
$15.8M Buy
27,490
+835
+3% +$481K 0.07% 72
2022
Q4
$14.7M Sell
26,655
-9,068
-25% -$4.99M 0.07% 75
2022
Q3
$18.1M Buy
35,723
+1,522
+4% +$772K 0.1% 58
2022
Q2
$18.6M Sell
34,201
-1,777
-5% -$965K 0.09% 59
2022
Q1
$21.3M Buy
35,978
+711
+2% +$420K 0.09% 52
2021
Q4
$23.5M Buy
35,267
+5,500
+18% +$3.67M 0.1% 45
2021
Q3
$17M Buy
29,767
+7,690
+35% +$4.39M 0.08% 48
2021
Q2
$11.1M Buy
22,077
+572
+3% +$289K 0.05% 64
2021
Q1
$9.81M Buy
21,505
+2,893
+16% +$1.32M 0.05% 66
2020
Q4
$8.67M Buy
18,612
+1,314
+8% +$612K 0.05% 64
2020
Q3
$7.64M Buy
17,298
+786
+5% +$347K 0.05% 69
2020
Q2
$5.98M Buy
16,512
+1,792
+12% +$649K 0.05% 74
2020
Q1
$4.18M Buy
14,720
+3,259
+28% +$924K 0.04% 80
2019
Q4
$3.72M Buy
11,461
+1,213
+12% +$394K 0.03% 104
2019
Q3
$2.99M Buy
10,248
+635
+7% +$185K 0.03% 115
2019
Q2
$2.82M Buy
9,613
+478
+5% +$140K 0.02% 116
2019
Q1
$2.5M Buy
9,135
+1,902
+26% +$521K 0.02% 121
2018
Q4
$1.62M Buy
+7,233
New +$1.62M 0.02% 157